Skip to main content

Advertisement

SpringerLink
Log in

New Drug Developments for Stroke: from Basics to Clinics

  • Comment
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, Abbasifard M, Abbasi-Kangevari M, Abd-Allah F, Abedi V, Abualhasan A. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;(20):795–820.

  2. Yang SH, et al. Precision medicine for ischemic stroke, let us move beyond time is brain. Transl Stroke Res. 2018;9:93–5.

    Article  PubMed  Google Scholar 

  3. Cohen JC, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264–72.

    Article  CAS  PubMed  Google Scholar 

  4. Sabatine MS, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–22.

    Article  CAS  PubMed  Google Scholar 

  5. Hu H, et al. Mutational landscape of secondary glioblastoma guides met-targeted trial in brain tumor. Cell. 2018;175:1665–1678.e1618.

    Article  CAS  PubMed  Google Scholar 

  6. Farkhondeh A, et al. Induced pluripotent stem cells for neural drug discovery. Drug Discov Today. 2019;24:992–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wang J, et al. Bioavailability of edaravone sublingual tablet versus intravenous infusion in healthy male volunteers. Clin Ther. 2018;40:1683–91.

    Article  CAS  PubMed  Google Scholar 

  8. Chen X, et al. Predicting the pharmacokinetic characteristics of edaravone intravenous injection and sublingual tablet through modeling and simulation. Clin Ther. 2020;42:428–38.

    Article  CAS  PubMed  Google Scholar 

  9. Absinta M, et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. eLife. 2017;6:e29738.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wang Y, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11–9.

    Article  CAS  PubMed  Google Scholar 

  11. Wang Y, et al. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ. 2019;365:l2211.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wang Y, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385:2520–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate Tao Xin from the Department of Applied Linguistics, School of Medical Humanities, Capital Medical University, for the language editing assistance.

Funding

This study was supported by grants from the National Natural Science Foundation of China (No. 81825007, 81901177, 82101358), Beijing Outstanding Young Scientist Program (No. BJJWZYJH01201910025030), Youth Beijing Scholar Program (No.010), Beijing Talent Project-Class A: Innovation and Development (No. 2018A12), “National Ten-Thousand Talent Plan”-Leadership of Scientific and Technological Innovation, Beijing Hospitals Authority Youth Programme (QML20200501), and the Young Elite Scientist Sponsorship Program from China Association for Science and Technology (2019QNRC001).

Author information

Author notes

  1. Weiqi Chen, Yicong Wang and Lingling Jiang contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    Weiqi Chen, Yicong Wang, Lingling Jiang, Yongjun Wang & Yilong Wang

  2. China National Clinical Research Center for Neurological Diseases, Beijing, China

    Weiqi Chen, Yicong Wang, Lingling Jiang, Yongjun Wang & Yilong Wang

  3. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China

    Yongjun Wang & Yilong Wang

  4. Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China

    Yongjun Wang

  5. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Beijing, China

    Yongjun Wang

  6. Chinese Institute for Brain Research, Beijing, China

    Yilong Wang

  7. Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China

    Yilong Wang

Authors
  1. Weiqi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yicong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lingling Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yongjun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yilong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yilong Wang.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Human and Animal Ethics

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

The work described in this manuscript has not been published previously and is not under consideration for publication elsewhere.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, W., Wang, Y., Jiang, L. et al. New Drug Developments for Stroke: from Basics to Clinics. Transl. Stroke Res. 15, 335–338 (2024). https://doi.org/10.1007/s12975-023-01130-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-023-01130-y

Search

Navigation